Skip to main content
Log in

Utilising CD3 counts in ATG dosing has economic benefit

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Lindsley J, Pickworth K, Blais D, Hasan AK, Feldman D.Rabbit antithymocyte globulin dosing and complications in heart transplant induction and rejection. 29th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation: 89-90 abstr. 70, 22 Apr 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Utilising CD3 counts in ATG dosing has economic benefit. Pharmacoecon. Outcomes News 578, 10 (2009). https://doi.org/10.2165/00151234-200905780-00022

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905780-00022

Keywords

Navigation